Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: San Diego, California, United States
Founded Date: 2013
Investor Type: For Profit
Total Funding: $720.7M
Technology: Anti-infective Drugs
Employee Number: 51-100
Estimated Revenue: $50M to $100M
Investors Number: 11
Industry: PharmTech